Induction of CD4 + CD25 + Foxp3 + T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34 + Cells

Transplant Immunology

Volumn 26, Issue 1, 2012, Pages 19-26

  Ge, Guanqun ^a   Tian, Puxun ^a   Liu, Hongbao ^a   Zheng, Jin ^a   Fan, Xiaohu ^b   Ding, Chenguang ^a   Jin, Zhankui ^a   Luo, Xiaohui ^a   Xue, Wujun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dendritic cells; Hematopoietic stem progenitor cells; Immunoglobulin like transcript 3; Lentivirus; T regulatory cells; Tolerance

Indexed keywords

B7 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LENTIVIRUS VECTOR; LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANTIGENS, CD80; ANTIGENS, CD86; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LENTIVIRUS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, REGULATORY; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 82955248134     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.10.001     Document Type: Article

References (39)

1. Cella M., Sallusto F., Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997, 9:10-16.
2. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296.
3. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
4. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711.
5. Min W.P., Zhou D., Ichim T.E., Strejan G.H., Xia X., Yang J., et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003, 170:1304-1312.
6. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001, 182:18-32.
7. Ristich V., Liang S., Zhang W., Wu J., Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005, 35:1133-1142.
8. Xiao B.G., Huang Y.M., Link H. Tolerogenic dendritic cells: the ins and outs of outcome. J Immunother 2006, 29:465-471.
9. Sheng S.D., Iwagaki H., Ozaki M., Ogino T., Kusaka S., Fujimoto Y., et al. Prolonged survival of donor-specific rat intestinal allograft by administration of bone-marrow-derived immature dendritic cells. Transpl Immunol 2005, 14:17-20.
10. Zhang X., Li M., Lian D., Zheng X., Zhang Z.X., Ichim T.E., et al. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol 2008, 127:313-321.
11. Miller G., Lahrs S., Pillarisetty V.G., Shah A.B., DeMatteo R.P. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res 2002, 62:5260-5266.
12. Hermans I.F., Ritchie D.S., Yang J., Roberts J.M., Ronchese F. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 2000, 164:3095-3101.
13. Chen W., Wu X., Levasseur D.N., Liu H., Lai L., Kappes J.C., et al. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 2000, 18:352-359.
14. Cui Y., Golob J., Kelleher E., Ye Z., Pardoll D., Cheng L. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 2002, 99:399-408.
15. Bello-Fernandez C., Matyash M., Strobl H., Pickl W.F., Majdic O., Lyman S.D., et al. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions. Hum Gene Ther 1997, 8:1651-1658.
16. Movassagh M., Baillou C., Cosset F.L., Klatzmann D., Guigon M., Lemoine F.M. High level of retrovirus-mediated gene transfer into dendritic cells derived from cord blood and mobilized peripheral blood CD34+ cells. Hum Gene Ther 1999, 10:175-187.
17. Szabolcs P., Gallardo H.F., Ciocon D.H., Sadelain M., Young J.W. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity. Blood 1997, 90:2160-2167.
18. Dyall J., Latouche J.B., Schnell S., Sadelain M. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 2001, 97:114-121.
19. Gruber A., Kan-Mitchell J., Kuhen K.L., Mukai T., Wong-Staal F. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 2000, 96:1327-1333.
20. Schroers R., Sinha I., Segall H., Schmidt-Wolf I.G., Rooney C.M., Brenner M.K., et al. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 2000, 1:171-179.
21. Dresch C., Edelmann S.L., Marconi P., Brocker T. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo. J Immunol 2008, 181:4495-4506.
22. Suciu-Foca N., Cortesini R. Central role of ILT3 in the T suppressor cell cascade. Cell Immunol 2007, 248:59-67.
23. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997, 185:1743-1751.
24. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 2004, 16:1055-1068.
25. Torkar M., Norgate Z., Colonna M., Trowsdale J., Wilson M.J. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex. Eur J Immunol 1998, 28:3959-3967.
26. Penna G., Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000, 164:2405-2411.
27. Vlad G., D'Agati V.D., Zhang Q.Y., Liu Z., Ho E.K., Mohanakumar T., et al. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 2008, 57:1878-1886.
28. Vlad G., Stokes M.B., Liu Z., Chang C.C., Sondermeijer H., Vasilescu E.R., et al. Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc. Hum Immunol 2009, 70:663-669.
29. Ju X.S., Hacker C., Scherer B., Redecke V., Berger T., Schuler G., et al. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 2004, 331:159-164.
30. Brenk M., Scheler M., Koch S., Neumann J., Takikawa O., Hacker G., et al. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J Immunol 2009, 183:145-154.
31. Adeegbe D., Bayer A.L., Levy R.B., Malek T.R. Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 2006, 176:7149-7153.
32. Nishimura E., Sakihama T., Setoguchi R., Tanaka K., Sakaguchi S. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 2004, 16:1189-1201.
33. Pu L.Y., Wang X.H., Zhang F., Li X.C., Yao A.H., Yu Y., et al. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery 2007, 142:67-73.
34. Akbar A.N., Vukmanovic-Stejic M., Taams L.S., Macallan D.C. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007, 7:231-237.
35. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 2003, 11:245-258.
36. Thomson A.W., Turnquist H.R., Zahorchak A.F., Raimondi G. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation 2009, 87:S86-S90.
37. Penna G., Roncari A., Amuchastegui S., Daniel K.C., Berti E., Colonna M., et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005, 106:3490-3497.
38. Wu J., Yi S., Ouyang L., Jimenez E., Simond D., Wang W., et al. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008, 85:1841-1848.
39. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003, 3:984-993.